Effect of Modified Shenling Baizhu San on Inflammatory Factors and Peripheral Blood T Lymphocyte Subsets in Spleen Deficiency Wetness Type Subacute Eczema
Classic Prescriptions|更新时间:2021-02-09
|
Effect of Modified Shenling Baizhu San on Inflammatory Factors and Peripheral Blood T Lymphocyte Subsets in Spleen Deficiency Wetness Type Subacute Eczema
Chinese Journal of Experimental Traditional Medical FormulaeVol. 25, Issue 5, Pages: 63-67(2019)
Zhi-ren YU, Jing SHI, Cai-xia WANG, et al. Effect of Modified Shenling Baizhu San on Inflammatory Factors and Peripheral Blood T Lymphocyte Subsets in Spleen Deficiency Wetness Type Subacute Eczema[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(5): 63-67.
DOI:
Zhi-ren YU, Jing SHI, Cai-xia WANG, et al. Effect of Modified Shenling Baizhu San on Inflammatory Factors and Peripheral Blood T Lymphocyte Subsets in Spleen Deficiency Wetness Type Subacute Eczema[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(5): 63-67. DOI: 10.13422/j.cnki.syfjx.20190330.
Effect of Modified Shenling Baizhu San on Inflammatory Factors and Peripheral Blood T Lymphocyte Subsets in Spleen Deficiency Wetness Type Subacute Eczema
选取本院2016年1月至2017年12月诊治的176例脾虚湿蕴型湿疹患者作为研究对象,随机分为对照组(88例)和观察组(88例),对照组给予盐酸左西替利嗪片和复方硝酸益康唑凝胶治疗,观察组在对照组的基础上给予参苓白术散加减,治疗4周。观察两组患者临床疗效、治疗前后瘙痒评分、严重度指数(severity index
EASI)评分、皮肤病生活质量表(dermatology quality of life scales
DQOLS)评分、炎症因子及外周血T淋巴细胞亚群水平变化情况;随访6个月观察患者的复发情况。
结果:
2
治疗后,观察组患者瘙痒评分和EASI评分较本组治疗前降低,且观察组明显低于对照组(
P
<
0.05);DQOLS评分较本组治疗前升高,且观察组明显高于对照组(
P
<
0.05)。观察组患者临床有效率明显高于对照组(
P
<
0.05)。治疗后,观察组患者白细胞介素(interleukins
IL)-1
β
,IL-2,IL-4,IL-5,肿瘤坏死因子(tumor necrosis factor
TNF)-
α
水平较本组治疗前降低,且观察组明显低于对照组(
P
<
0.05);两组CD4
+
,CD4
+
/CD8
+
水平较本组治疗前升高,且观察组明显高于对照组(
P
<
0.05)。随访6个月,观察组患者复发率明显低于对照组(
P
<
0.05)。
结论:
2
参苓白术散加减通过抑制患者炎症反应,增强免疫功能,从而提高临床疗效。
Abstract
Objective:
2
To observe the clinical efficacy modified Shenling Baizhu San in treating patients with spleen deficiency wetness type subacute eczema
and its effect on the inflammatory factors and peripheral blood T lymphocyte subsets
so as to provide a theoretical basis for clinical treatment.
Method:
2
Totally 176 cases of spleen deficiency wetness type subacute eczema treated at our hospital from Jan. 2016 to Dec. 2017 were selected and randomly divided into control group (88 cases) and observation group (88 cases). Control group was treated with levocetirizine hydrochloride tablets and compound econazole nitrate gel
and observation group was given modified Shenling Baizhu San in addition to therapy of control group for 4 weeks. The clinical efficacy
pruritus score
severity index(EASI)score
dermatology quality of life scales(DQOLS) score and recurrence rate were observed
and inflammatory factor and peripheral blood T lymphocyte subgroup level were detected.
Result:
2
After treatment
the pruritus score and EASI score in observation group were lower than those before treatment (
P
<
0.05)
and those of observation group were significantly lower than those of control group (
P
<
0.05). However
the DQOLS score was higher than that before treatment
and significantly higher than that of control group (
P
<
0.05). The clinical effective rate of observation group was significantly higher than that of control group (
P
<
0.05). After treatment
the levels of interleukins(IL)-1
β
IL-2
IL-4
IL-5 and tumor necrosis factor(TNF)-
α
in observation group were lower than those before treatment (
P
<
0.05)
and the levels of CD4
+
and CD4
+
/CD8
+
were higher than those of before treatment
and significantly higher than those of control group (
P
<
0.05). During the 6-month follow-up
the recurrence rate of observation group was significantly lower than that of control group (
P
<
0.05).
Conclusion:
2
Modified Shenling Baizhu San could enhance the clinical efficacy by inhibiting the inflammatory reaction and regulating the immune function of patients.
关键词
Keywords
references
Fischer A H , Shin D B , Margolis D J , et al . Racial and ethnic differences in health care utilization for childhood eczema: an analysis of the 2001-2013 medical expenditure panel surveys [J]. J Am Acad Dermatol , 2017 , 77 ( 6 ): 1060 - 1067 .
Lubbes S , Rustemeyer T , Sillevis S J , et al . Contact sensitization in Dutch children and adolescents with and without atopic dermatitis-a retrospective analysis [J]. Contact Dermatitis , 2017 , 76 ( 3 ): 151 - 159 .
CAI J , LIU W , HU Y , et al . Household environment, lifestyle behaviors, and dietary habits in relation to childhood atopic eczema in Shanghai, China [J]. Int Arch Occup Environ Health , 2017 , 90 ( 1 ): 141 - 159 .
Baron S E , Cohen S N , Archer C B. Guidance on the diagnosis and clinical management of atopic eczema [J]. Clin Exp Dermatol , 2012 , 37 ( Suppl 1 ): 7 - 12 .
Sheikhi A , Giti H , Heibor M R , et al . Lactobacilus delbrueckii subsp. Bulgaricus modulates the secretion of Th1/Th2 and treg cell-related cytokines by PBMCs from patients with atopic dermatitis [J]. Drug Res (Stuttg) , 2017 , 67 ( 12 ): 724 - 729 .
Funakoshi-Tago M , Tanabe S , Tago K , et al . Licochalcone A potently inhibits tumor necrosis factor alpha-induced nuclear factorkappa Bactivation through the direct inhibition of Ikappa B kinase complex activation [J]. Mol Pharmacol , 2009 , 76 ( 4 ): 745 - 753 .
WANG C H , DUAN H J , HE L C. Inhibitory effect of atractylenolide I on angiogenesis in chronic inflammation in vivo and in vitro [J]. Eur J Pharmacol , 2009 , 612 ( 1/3 ): 143 - 152 .